NasdaqGS:FTRELife Sciences
A Look At Fortrea Holdings (FTRE) Valuation After Weak Q4 Results And Soft 2025–2026 Guidance
Fortrea Holdings (FTRE) shares came under pressure after the contract research group reported fourth quarter 2025 results with revenue and adjusted earnings below analyst forecasts, along with full year 2025 and 2026 guidance that trailed market expectations.
See our latest analysis for Fortrea Holdings.
At a share price of US$10.72, Fortrea has recorded a sharp 30 day share price return of a 37.13% decline and a 1 year total shareholder return of a 22.60% loss. This suggests momentum has...